» Articles » PMID: 11402317

DNA Microarrays Identification of Primary and Secondary Target Genes Regulated by P53

Overview
Journal Oncogene
Date 2001 Jun 13
PMID 11402317
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

The transcriptional program regulated by the tumor suppressor p53 was analysed using oligonucleotide microarrays. A human lung cancer cell line that expresses the temperature sensitive murine p53 was utilized to quantitate mRNA levels of various genes at different time points after shifting the temperature to 32 degrees C. Inhibition of protein synthesis by cycloheximide (CHX) was used to distinguish between primary and secondary target genes regulated by p53. In the absence of CHX, 259 and 125 genes were up or down-regulated respectively; only 38 and 24 of these genes were up and down-regulated by p53 also in the presence of CHX and are considered primary targets in this cell line. Cluster analysis of these data using the super paramagnetic clustering (SPC) algorithm demonstrate that the primary genes can be distinguished as a single cluster among a large pool of p53 regulated genes. This procedure identified additional genes that co-cluster with the primary targets and can also be classified as such genes. In addition to cell cycle (e.g. p21, TGF-beta, Cyclin E) and apoptosis (e.g. Fas, Bak, IAP) related genes, the primary targets of p53 include genes involved in many aspects of cell function, including cell adhesion (e.g. Thymosin, Smoothelin), signaling (e.g. H-Ras, Diacylglycerol kinase), transcription (e.g. ATF3, LISCH7), neuronal growth (e.g. Ninjurin, NSCL2) and DNA repair (e.g. BTG2, DDB2). The results suggest that p53 activates concerted opposing signals and exerts its effect through a diverse network of transcriptional changes that collectively alter the cell phenotype in response to stress.

Citing Articles

A molecular mechanism for the "digital" response of p53 to stress.

Safieh J, Chazan A, Saleem H, Vyas P, Danin-Poleg Y, Ron D Proc Natl Acad Sci U S A. 2023; 120(49):e2305713120.

PMID: 38015851 PMC: 10710088. DOI: 10.1073/pnas.2305713120.


The Expression Pattern and Clinical Significance of Lysyl Oxidase Family in Gliomas.

Xie W, Peng Z, Zhou X, Xia Q, Chen M, Zheng X Dokl Biochem Biophys. 2023; 510(1):132-143.

PMID: 37582875 DOI: 10.1134/S1607672922600269.


BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting.

Sorbi C, Belluti S, Atene C, Marocchi F, Linciano P, Roy N Int J Mol Sci. 2023; 24(11).

PMID: 37298633 PMC: 10253401. DOI: 10.3390/ijms24119684.


Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040.

Sinha B, Tokar E, Li J, Bushel P Cancers (Basel). 2023; 15(1).

PMID: 36612280 PMC: 9818835. DOI: 10.3390/cancers15010285.


Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer.

Li Z, Spoelstra N, Sikora M, Sams S, Elias A, Richer J NPJ Breast Cancer. 2022; 8(1):62.

PMID: 35538119 PMC: 9090919. DOI: 10.1038/s41523-022-00426-w.